| Literature DB >> 25381727 |
Yoshikazu Otsubo1, Ikuo Okafuji2, Toshimasa Shimizu3, Fumiaki Nonaka3, Kei Ikeda4, Katsumi Eguchi3.
Abstract
Blau syndrome (BS) is an autosomal dominant autoinflammatory disease associated with NOD2 gene mutations. It is characterized by arthritis, skin rash, and uveitis. Here, we report contrasting outcomes of a daughter and her mother with BS. Their long-term follow-up revealed the efficacy of anti-tumor necrosis factor inhibitor (TNF) with respect to BS. Joint findings of BS feature tenosynovitis over articular synovitis on ultrasonography. BS might be one of the differential diagnoses of juvenile idiopathic arthritis and rheumatoid arthritis.Entities:
Keywords: Anti-TNF inhibitor; Blau syndrome; NOD2 gene; Tenosynovitis; Ultrasonography
Mesh:
Substances:
Year: 2014 PMID: 25381727 DOI: 10.3109/14397595.2014.964388
Source DB: PubMed Journal: Mod Rheumatol ISSN: 1439-7595 Impact factor: 3.023